RARE Annual Long Term Debt
$30.57 M
+$10.76 M+54.31%
31 December 2023
Summary:
As of January 23, 2025, RARE annual long term debt is $30.57 million, with the most recent change of +$10.76 million (+54.31%) on December 31, 2023. During the last 3 years, it has fallen by -$8.68 million (-22.11%). RARE annual long term debt is now -22.11% below its all-time high of $39.25 million, reached on December 31, 2020.RARE Long Term Debt Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
RARE Quarterly Long Term Debt
$23.66 M
-$2.08 M-8.10%
30 September 2024
Summary:
As of January 23, 2025, RARE quarterly long term debt is $23.66 million, with the most recent change of -$2.08 million (-8.10%) on September 30, 2024. Over the past year, it has dropped by -$10.90 million (-31.54%). RARE quarterly long term debt is now -39.73% below its all-time high of $39.25 million, reached on December 31, 2020.RARE Quarterly Long Term Debt Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
RARE Long Term Debt Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | +54.3% | -31.5% |
| 3 y3 years | -22.1% | -29.1% |
| 5 y5 years | +100.0% | -24.2% |
RARE Long Term Debt High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | -1.1% | +54.3% | -31.5% | +59.4% |
| 5 y | 5-year | -22.1% | +54.3% | -39.7% | +59.4% |
| alltime | all time | -22.1% | -39.7% |
Ultragenyx Pharmaceutical Long Term Debt History
| Date | Annual | Quarterly |
|---|---|---|
| Sept 2024 | - | $23.66 M(-8.1%) |
| June 2024 | - | $25.74 M(-8.0%) |
| Mar 2024 | - | $27.98 M(-8.5%) |
| Dec 2023 | $30.57 M(+54.3%) | $30.57 M(-11.5%) |
| Sept 2023 | - | $34.55 M(+132.8%) |
| June 2023 | - | $14.85 M(-14.4%) |
| Mar 2023 | - | $17.34 M(-12.5%) |
| Dec 2022 | $19.81 M(-35.9%) | $19.81 M(-13.3%) |
| Sept 2022 | - | $22.86 M(-11.7%) |
| June 2022 | - | $25.90 M(-7.6%) |
| Mar 2022 | - | $28.04 M(-9.3%) |
| Dec 2021 | $30.90 M | $30.90 M(-7.3%) |
| Date | Annual | Quarterly |
|---|---|---|
| Sept 2021 | - | $33.34 M(-7.0%) |
| June 2021 | - | $35.86 M(-2.4%) |
| Mar 2021 | - | $36.75 M(-6.4%) |
| Dec 2020 | $39.25 M(+31.9%) | $39.25 M(+7.0%) |
| Sept 2020 | - | $36.67 M(+1.0%) |
| June 2020 | - | $36.31 M(+3.9%) |
| Mar 2020 | - | $34.96 M(+17.5%) |
| Dec 2019 | $29.76 M(>+9900.0%) | $29.76 M(-4.6%) |
| Sept 2019 | - | $31.21 M(-5.3%) |
| June 2019 | - | $32.97 M(+43.4%) |
| Mar 2019 | - | $22.98 M(>+9900.0%) |
| Dec 2018 | $0.00 | $0.00 |
FAQ
- What is Ultragenyx Pharmaceutical annual long term debt?
- What is the all time high annual long term debt for Ultragenyx Pharmaceutical?
- What is Ultragenyx Pharmaceutical annual long term debt year-on-year change?
- What is Ultragenyx Pharmaceutical quarterly long term debt?
- What is the all time high quarterly long term debt for Ultragenyx Pharmaceutical?
- What is Ultragenyx Pharmaceutical quarterly long term debt year-on-year change?
What is Ultragenyx Pharmaceutical annual long term debt?
The current annual long term debt of RARE is $30.57 M
What is the all time high annual long term debt for Ultragenyx Pharmaceutical?
Ultragenyx Pharmaceutical all-time high annual long term debt is $39.25 M
What is Ultragenyx Pharmaceutical annual long term debt year-on-year change?
Over the past year, RARE annual long term debt has changed by +$10.76 M (+54.31%)
What is Ultragenyx Pharmaceutical quarterly long term debt?
The current quarterly long term debt of RARE is $23.66 M
What is the all time high quarterly long term debt for Ultragenyx Pharmaceutical?
Ultragenyx Pharmaceutical all-time high quarterly long term debt is $39.25 M
What is Ultragenyx Pharmaceutical quarterly long term debt year-on-year change?
Over the past year, RARE quarterly long term debt has changed by -$10.90 M (-31.54%)